Work

A Phase I Study Of AC220 (Quizartinib) In Combination With Cytarabine and Etoposide In Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances In Childhood Leukemia & Lymphoma (TACL) Study

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.624.624

Authors: Todd Michael Cooper, Jemily Malvar, Jeannette Cassar, Elena Eckroth, Richard Sposto, Paul Gaynon, Steven Dubois, Lia Gore, Margaret E. Macy, Keith J. August, Blythe Thomson, Javier Oesterheld, Guy Gammon, Daniel Magoon, Colleen E. Annesley, Patrick Brown

Institutions: Henrietta Egleston Hospital for Children, Children's Healthcare of Atlanta, Children's Hospital Los Angeles, University of California, San Francisco, University of Colorado Cancer Center, University of Colorado Anschutz, University of Colorado Denver, Children's Mercy Hospital, Seattle Children's Hospital, Levine Children's Hospital, Johns Hopkins University, Johns Hopkins Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4247946066

FWCI: 1.188

Cites:

Cited by: 7

Related to: 10